| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/12/2012 | CN102813743A Traditional Chinese medicine capsule for treating knee-joint soreness |
| 12/12/2012 | CN102813727A Preparation method of Momordica cochinchinensis Tougu ointment |
| 12/12/2012 | CN102813302A Medicinal semicircular knee pad |
| 12/12/2012 | CN102526419B Blood circulation invigorating and pain relieving Chinese medicinal composition and preparation process and application thereof |
| 12/12/2012 | CN102423310B Application of salvianolic acid C in preparation of drugs for prevention and treatment of hyperuricemia |
| 12/12/2012 | CN102178484B Konjak facecloth having washing and massaging functions and preparation method thereof |
| 12/12/2012 | CN102144982B Minodronate tablets and preparation method thereof |
| 12/12/2012 | CN102000052B Application of taxol and taxol derivatives to pharmacy |
| 12/12/2012 | CN101925357B Formulas comprising calcium, magnesium, zinc, and vitamin D3 for prevention and amelioration of osteoporosis |
| 12/12/2012 | CN101919913B Composition with effect of treating rheumatoid arthritis |
| 12/12/2012 | CN101678014B 杂环激酶调节剂 Heterocycle kinase modulators |
| 12/12/2012 | CN101537080B Pine needle health-care medicinal liquor with efficacy of dispersing pathogenic wind and removing dampness and preparation method thereof |
| 12/12/2012 | CN101057885B Medicinal composition for treating osteoporosis and preparations and application thereof |
| 12/11/2012 | US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use |
| 12/11/2012 | US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 12/11/2012 | US8329742 Macrocyclic compounds useful as pharmaceuticals |
| 12/11/2012 | US8329662 Prodrug of an ICE inhibitor |
| 12/11/2012 | US8329641 Antiischemic agents; anticholesterol agents; cardiovascular disorders; using granulocyte colony stimulating agents |
| 12/11/2012 | US8329637 Immunosuppression and antigen-specific immune tolerance; allogenic organ rejection, graft versus host disease, type I diabetes, rheumatoid arthritis, multiple sclerosis, systemic lupus erithematosus; chronic inflammatory disease; Crohn's disease and ulcerative colitis; asthma |
| 12/11/2012 | US8329220 Controlled release formulations |
| 12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 12/11/2012 | CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/06/2012 | WO2012167226A2 Method, composition, and articles for improving joint lubrication |
| 12/06/2012 | WO2012167077A1 Blockade of inflammatory proteases with theta - defensins |
| 12/06/2012 | WO2012166003A1 Method for filling bone cavity formations with calcium |
| 12/06/2012 | WO2012165900A2 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
| 12/06/2012 | WO2012165737A1 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
| 12/06/2012 | WO2012165682A1 Bone forming peptide 4 for promoting osteogenesis or vascularization and use thereof |
| 12/06/2012 | WO2012165407A1 Method for screening for therapeutic agent for cartilage diseases, and genetically modified cartilage cell for use in treatment of cartilage diseases |
| 12/06/2012 | WO2012164121A1 Method for obtaining a tissue-engineering product for regeneration of cartilaginous tissue |
| 12/06/2012 | WO2012163887A1 Inhibition of bone resorption with rankl binding peptides |
| 12/06/2012 | WO2012163792A1 Novel p2x7r antagonists and their use |
| 12/06/2012 | WO2012163563A1 New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| 12/06/2012 | WO2012163456A1 Novel p2x7r antagonists and their use |
| 12/06/2012 | WO2012050370A3 Composition for preventing or treating rheumatoid arthritis containing a gamma secretase inhibitor as an active ingredient |
| 12/06/2012 | WO2012012891A8 Compounds, compositions and methods for treatment of arthritis |
| 12/06/2012 | WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 12/06/2012 | US20120309842 Processes for the preparation of cinacalcet |
| 12/06/2012 | US20120309833 Novel bexarotene analogs |
| 12/06/2012 | US20120309821 Use of epigallocatechin-3-gallate for immune regulation |
| 12/06/2012 | US20120309820 Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids |
| 12/06/2012 | US20120309817 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/06/2012 | US20120309799 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 12/06/2012 | US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases |
| 12/06/2012 | US20120309776 Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors |
| 12/06/2012 | US20120309759 Screening Method and Compounds for Modulating Telomerase Activity |
| 12/06/2012 | US20120309758 Modulators of atp-binding cassette transporters |
| 12/06/2012 | US20120309747 Protein kinase inhibitors |
| 12/06/2012 | US20120309746 Triazolopyridine compounds |
| 12/06/2012 | US20120309735 Aminopyrimidines as syk inhibitors |
| 12/06/2012 | US20120309723 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 12/06/2012 | US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
| 12/06/2012 | US20120309709 Ion-Channel Regulator Compositions and Methods of Using Same |
| 12/06/2012 | US20120309685 Purified emd protein composition |
| 12/06/2012 | US20120309675 Peptide bfp4 for promoting osteogenesis or vascularization and use thereof |
| 12/06/2012 | US20120309674 Pseudodipeptides as mmp inhibitors |
| 12/06/2012 | US20120309673 Cysteine protease inhibitors |
| 12/06/2012 | US20120309672 Treatment of extracellular matrix to reduce inflammation |
| 12/06/2012 | US20120308665 Material for osteoplasty and tissue engineering |
| 12/06/2012 | US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery |
| 12/06/2012 | US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels |
| 12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
| 12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
| 12/06/2012 | US20120308578 SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES |
| 12/06/2012 | US20120308575 Full human anti-tnf-alpha monoclonal antibody, preparation method and use thereof |
| 12/06/2012 | US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
| 12/06/2012 | US20120308561 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 12/06/2012 | US20120308556 Processed ecm materials with enhanced component profiles |
| 12/06/2012 | US20120308537 Use Of Collagen Type VII For Maintaining And Re-Inducing Osteogenic Abilities Of Mesenchymal Stem Cells |
| 12/06/2012 | US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment |
| 12/06/2012 | US20120308532 Composition for the treatment of a bone fracture |
| 12/06/2012 | US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 12/06/2012 | US20120308514 Human antibodies that bind human il-12 and methods for producing |
| 12/06/2012 | US20120308510 Method, composition, and articles for improving joint lubrication |
| 12/06/2012 | US20120308493 Pawpaw and/or peach derived composition |
| 12/06/2012 | US20120308483 Treatment of Sleep Disturbances |
| 12/06/2012 | US20120308480 Humanized antibodies against tl1a |
| 12/06/2012 | CA2838059A1 Method, composition, and articles for improving joint lubrication |
| 12/06/2012 | CA2837858A1 Blockade of inflammatory proteases with theta - defensins |
| 12/06/2012 | CA2837697A1 A method for filling bone cavities with calcium |
| 12/06/2012 | CA2837556A1 Antibodies specific for tgf-beta |
| 12/06/2012 | CA2837437A1 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
| 12/06/2012 | CA2835340A1 Inhibition of bone resorption with rankl binding peptides |
| 12/05/2012 | EP2530068A1 New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| 12/05/2012 | EP2529753A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 12/05/2012 | EP2529752A1 Use for production of therapeutic agent or prophylactic agent for osteoarthritis |
| 12/05/2012 | EP2529751A1 Injectable solution containing therapeutic agent for osteoarthritis |
| 12/05/2012 | EP2528607A2 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 12/05/2012 | CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 12/05/2012 | CN102811763A Proteoglycan-containing microneedle array |
| 12/05/2012 | CN102811738A Use for production of therapeutic agent or prophylactic agent for osteoarthritis |
| 12/05/2012 | CN102811737A Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 12/05/2012 | CN102807973A A variant form of urate oxidase and use thereof |
| 12/05/2012 | CN102807617A Antibodies to M-CSF |
| 12/05/2012 | CN102807613A Secreted protein with chemotactic activity and medicament usage thereof |
| 12/05/2012 | CN102805847A Medicine for treating arthralgia |
| 12/05/2012 | CN102805819A Fructus aurantii antalgic pills |
| 12/05/2012 | CN102805817A Medicine for treating rheumatism and rheumatoid diseases |
| 12/05/2012 | CN102805816A Drug composition for treating senium primary osteoarthritis and preparation method thereof |